OrbusNeich unveils device to prevent restenosis in DAPT patients

05/29/2013 | MedGadget.com

OrbusNeich has introduced its COMBO Dual Therapy Stent, designed to prevent the recurrence of stenosis, or narrowed blood vessels, in patients undergoing dual antiplatelet therapy. The sirolimus-eluting stent is covered with Anti-CD34 antibodies that absorb endothelial progenitor cells from passing blood to speed up the healing process.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY